Latest filingSep 26, 2026Most recent Form 4
NKTR
NEKTAR THERAPEUTICS
NasdaqHealthcarePharmaceutical Preparations
Insider activity for last month from 08/26 to 09/26. Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total buying$00 buys
Total selling$00 sells
Net open-market+$05 insiders
Open-market mix
Buy vs sell distribution by transaction countInsider activity report
Monthly purchases, sales and code-A awards Buys Sells Awards / grants (A)
Code A includes awards, grants and other acquisitions; these are not open-market buys.
Distinct insiders active
Reporting-owner CIKs by month · peak Sep 2026 (5)Aug 2026Sep 2026
Top insiders
By absolute net value across the selected period- WA+$0
- GS+$0
- CR+$0
- BD+$0
- AR+$0
Filing detail checks
Secondary metrics for the selected periodTransaction codes
By Form 4 transaction code in selected period10transactionstxns
- A · Grants / awards · dominant10 · 100%
Activity by reported role
A joint filing can contribute to multiple roles10transactionstxns
- Director · dominant10 · 100%
Reported Holdings After
Separated by insider, security, and ownership type
Ajer Jeffrey RobertCommon Stock · Direct
4,277Sep 23, 2026
Ajer Jeffrey RobertStock Option · Direct
4,000Sep 23, 2026
Brainard DianaStock Option · Direct
4,000Sep 23, 2026
Brainard DianaCommon Stock · Direct
3,904Sep 23, 2026
Chess RobertCommon Stock · Direct
19,019Sep 23, 2026
Chess RobertStock Option · Direct
4,000Sep 23, 2026
Greer R ScottCommon Stock · Direct
22,239Sep 23, 2026
Greer R ScottStock Option · Direct
4,000Sep 23, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Each cell is one day · intensity = transactions · buys green, sells redAug 26 → Sep 26
LessMore
Filing-only signals
Deterministic matches in the selected period
No filing-only signal badges matched this period.
NKTR transaction history
Filters apply within this company and selected period by defaultLatest insider transactions
Form 4 filings from last month. Click any column to sort; click it again to flip the order.
| ID | Ticker | Insider | Role | Type | Shares | Value | Code | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|
| #230053 | NKTR | Whitfield Roy A | DIR | grant | 4.00k | $0 | A | 09/26 | 09/23 |
| #230052 | NKTR | Whitfield Roy A | DIR | grant | 2.00k | $0 | A | 09/26 | 09/23 |
| #230051 | NKTR | Greer R Scott | DIR | grant | 4.00k | $0 | A | 09/26 | 09/23 |
| #230050 | NKTR | Greer R Scott | DIR | grant | 2.00k | $0 | A | 09/26 | 09/23 |
| #230049 | NKTR | Chess Robert | DIR | grant | 4.00k | $0 | A | 09/26 | 09/23 |
| #230048 | NKTR | Chess Robert | DIR | grant | 2.00k | $0 | A | 09/26 | 09/23 |
| #230047 | NKTR | Brainard Diana | DIR | grant | 4.00k | $0 | A | 09/26 | 09/23 |
| #230046 | NKTR | Brainard Diana | DIR | grant | 2.00k | $0 | A | 09/26 | 09/23 |
| #230045 | NKTR | Ajer Jeffrey Robert | DIR | grant | 4.00k | $0 | A | 09/26 | 09/23 |
| #230044 | NKTR | Ajer Jeffrey Robert | DIR | grant | 2.00k | $0 | A | 09/26 | 09/23 |
NEKTAR THERAPEUTICS Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at NEKTAR THERAPEUTICS?
WHITFIELD ROY A, GREER R SCOTT, CHESS ROBERT, Brainard Diana, Ajer Jeffrey Robert.
When was the latest reported open-market purchase?
No code-P purchase is available for this period.
When was the latest reported open-market sale?
No code-S sale is available for this period.
What is the recent purchase and sale balance?
No code-P purchases or code-S sales were reported in the selected period.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.